Announcing Proactol™, a clinically proven medical device product (MDD 93/42/ECC) for the treatment of obesity. Proactol™ is fully proven, approved by the MRHA and bears the official EU CE stamp.

Proactol™ is clinically proven to bind over 27% of the dietary fat intake it does this by bonding to the fat molecules in your food and making them to large to be absorbed in your digestive tract.

Proactol™ will also reduce your calorie intake from food. It suppresses appetite and reduces your food cravings that make diets so hard to stick to. And it’s 100% clinically proven to reduce excess body weight and blood cholesterol levels.

Interested in selling Proactol? (Click Here)